Article

Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness.

Department of Economics, Center for Healthcare Policy and Research, University of California, Davis, California 95817, USA.
Obstetrics and Gynecology (Impact Factor: 4.37). 11/2010; 116(5):1158-70. DOI: 10.1097/AOG.0b013e3181f88e72
Source: PubMed

ABSTRACT To estimate outcomes and costs of surveillance strategies after treatment for high-grade cervical intraepithelial neoplasia (CIN).
A hypothetical cohort of women was evaluated after treatment for CIN 2 or 3 using a Markov model incorporating data from a large study of women treated for CIN, systematic reviews of test accuracy, and individual preferences. Surveillance strategies included initial conventional or liquid-based cytology, human papillomavirus testing, or colposcopy 6 months after treatment, followed by annual or triennial cytology. Estimated outcomes included CIN, cervical cancer, cervical cancer deaths, life expectancy, costs, cost per life-year, and cost per quality-adjusted life-year.
Conventional cytology at 6 and 12 months, followed by triennial cytology, was least costly. Compared with triennial cytology, annual cytology follow-up reduced expected cervical cancer deaths by 73% to 77% and had an average incremental cost per life-year gained of $69,000 to $81,000. For colposcopy followed by annual cytology, the incremental cost per life-year gained ranged from $70,000 to more than $1 million, depending on risk. Between-strategy differences in mean additional life expectancy per woman were less than 4 days; differences in mean incremental costs per woman were as high as $822. In the cost-utility analysis, colposcopy at 6 months followed by annual cytology had an incremental cost per quality-adjusted life-year of less than $5,500. Human papillomavirus testing or liquid-based cytology added little to no improvement to life-expectancy with higher costs.
Annual conventional cytology surveillance reduced cervical cancers and cancer deaths compared with triennial cytology. For high risk of recurrence, a strategy of colposcopy at 6 months increased life expectancy and quality-adjusted life expectancy. Human papillomavirus testing and liquid-based cytology increased costs, but not effectiveness, compared with traditional approaches.

0 Bookmarks
 · 
139 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is the largest cancer screening program for low-income women in the United States. This study updates previous estimates of the costs of delivering preventive cancer screening services in the NBCCEDP.
    Cancer 08/2014; 120 Suppl 16:2604-11. DOI:10.1002/cncr.28816 · 5.20 Impact Factor
  • JAMA Internal Medicine 05/2014; 174(7). DOI:10.1001/jamainternmed.2014.576 · 13.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Las neoplasias intraepiteliales (neoplasia intraepitelial cervical [CIN]) preceden a los carcinomas epidermoides, que constituyen alrededor del 80-90% de las lesiones invasivas del cuello uterino. La infección persistente de la mucosa cervical por el virus del papiloma humano (VPH) constituye una condición necesaria para el desarrollo del cáncer del cuello uterino y de las CIN. Los mecanismos de la carcinogénesis relacionada con la infección por VPH se conocen cada vez mejor en la actualidad. La integración del genoma viral en el genoma celular interviene en las primeras fases de la evolución hacia un cáncer. Los datos epidemiológicos recientes sugieren un aumento de la incidencia y de la prevalencia de las CIN y una disminución del promedio de edad de las pacientes portadoras de estas lesiones. La existencia de lesiones precancerosas (CIN) durante un período prolongado explica la pertinencia y la eficacia de la detección sistemática del cáncer del cuello uterino. La colposcopia desempeña un papel fundamental en el diagnóstico de las CIN. Es indispensable para dirigir las biopsias. Permite precisar la topografía de las lesiones y, asociada a la citología y al estudio histológico de la biopsia dirigida, contribuye a las indicaciones terapéuticas. Una vacunación profiláctica permite prevenir la infección por el virus del papiloma humano y sus consecuencias, como las CIN, con una eficacia cercana al 100% si se realiza en condiciones óptimas. Las CIN son lesiones asintomáticas. Su tratamiento sólo está justificado para evitar su evolución a un cáncer. Se puede proponer la abstinencia terapéutica, en determinadas circunstancias, para las lesiones susceptibles de experimentar una regresión espontánea. La elección del método y de la extensión del tratamiento debe buscar a la vez su eficacia y la menor iatrogenia posible.
    09/2013; 49(3):1–23. DOI:10.1016/S1283-081X(13)65435-1